EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Combined immune checkpoint inhibitor–induced type 1 diabetes: a rare but serious endocrinopathy

Kasra Emami iD, Sonia Goyal, Vishal Akula, Peggy Amoakohene

JCEM Case Reports · 23.02.2026 · 4 (3)

DOI: 10.1210/jcemcr/luag041 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 18.03.2026. Verfasst von Kasra Emami und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mary Washington Healthcare, Fredericksburg, VA 22401, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapies have a class of medications called checkpoint inhibitors that can induce endocrinopathies including hypothyroidism, hypophysitis, and adrenalitis. This case illustrates a 72-year-old woman with recently diagnosed non-small cell lung cancer (NSCLC) who developed immune-mediated hypothyroidism and subsequent type 1 diabetes mellitus (T1DM) presenting as diabetic ketoacidosis (DKA) after 3 months of combination immunotherapy with nivolumab and ipilimumab. After her hospitalization, she was discharged on insulin. Our clinical case not only provides more literature on the risks involved with immunotherapy but also shows a rare outcome with checkpoint inhibitor–induced T1DM.

Schlagwörter

Stichwörter der Autor:innen

diabeteshypothyroidismimmune checkpoint inhibitorsipilimumabnivolumab

Autor:innen und Institutionen

  • Department of Internal Medicine, Mary Washington Healthcare, Fredericksburg, VA 22401, USA.

ORCID-Profile: Kasra Emami

Zitieren

APA

Emami, K., Goyal, S., Akula, V., & Amoakohene, P. (2026). Combined immune checkpoint inhibitor–induced type 1 diabetes: a rare but serious endocrinopathy. JCEM Case Reports, 4(3). https://doi.org/10.1210/jcemcr/luag041

Vancouver

Emami K, Goyal S, Akula V, Amoakohene P. Combined immune checkpoint inhibitor–induced type 1 diabetes: a rare but serious endocrinopathy. JCEM Case Reports. 2026;4(3). doi:10.1210/jcemcr/luag041

BibTeX
@article{Emami2026,
  author = {Emami, Kasra and Goyal, Sonia and Akula, Vishal and Amoakohene, Peggy},
  title = {Combined immune checkpoint inhibitor–induced type 1 diabetes: a rare but serious endocrinopathy},
  journal = {JCEM Case Reports},
  year = {2026},
  volume = {4},
  number = {3},
  doi = {10.1210/jcemcr/luag041}
}
Kostenlos starten →